Endocrinology
Articles tagged with Endocrinology
The 28th European Congress of Endocrinology (ECE) hosts the largest gathering of endocrine specialists in Europe
Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a complex hormonal disorder impacting 1 in 8 women globally, affecting weight, metabolism, mental health, skin, and the reproductive system. The name change aims to improve diagnosis and care for this previously misunderstood condition.
Insulin resistance during pregnancy linked to higher abdominal fat in girls
Research found that girls born to mothers with higher insulin resistance during pregnancy are more likely to have more abdominal fat at age 7. Maternal insulin resistance was not associated with body fat in boys, suggesting girls may be more susceptible to the mother's insulin resistance during late pregnancy.
Environmental chemicals may interfere in infants’ bone development
Research suggests that exposure to environmental pollutants in early life can negatively affect bone development. A study of 88 healthy infants found associations between certain endocrine-disrupting chemicals and lower bone mineral density, emphasizing the importance of protecting vulnerable windows during pregnancy and after birth.
Call for coordinated action to close Africa’s bone health gap
A new editorial by IOF members highlights the alarming high post-fracture mortality in Africa and emphasizes the need for a targeted, Africa-driven strategy. The authors propose five strategic priorities to build bone health into national health systems, education, and policy.
Hormone health climbs the policy agenda as endocrine leaders meet for European Society of Endocrinology’s first Summit of the Presidents
The summit brought together endocrine leaders to identify opportunities to work closely together on increasing the visibility of endocrine health in policy decisions. Early findings from a workforce survey revealed challenges including long patient waiting times and retention concerns among early-career clinicians.
New study finds higher dementia risk in insulin-requiring diabetes
The 28th European Congress of Endocrinology (ECE) starts tomorrow
NIH-funded study suggests that testosterone suppresses brain tumor growth in males
A NIH-funded study discovered that testosterone may play a key role in limiting brain tumor growth in men by suppressing inflammation and stress hormone production. Analysis of over 1,300 men with glioblastoma found that supplemental testosterone was significantly associated with improved survival rates.
Italian researchers Pilatone and Milan win Endocrine Society’s 2026 Endocrine Images Art Competition
Italian researchers Anna Pilatone and Gabriella Milan won the Endocrine Society's 2026 Endocrine Images Art Competition with their image of a pre-adipocyte cell, highlighting the complexity of adipose tissue in obesity. The winning entry will be displayed at ENDO 2026 and featured in Endocrine News magazine.
New study reveals how weight-loss drugs reshape the brain’s reward system
A new study from the University of Virginia finds that next-generation GLP-1 drugs can alter brain circuits controlling motivation and reward. The research shows that these drugs not only suppress appetite but also influence how the brain values food, helping explain their effectiveness and side effects.
World Hormone Day 2026
The European Society of Endocrinology organizes World Hormone Day to educate the public about hormone-related health issues. Global endocrine disorders affect millions worldwide, emphasizing the need for proper hormone balance.
Vitamin D may help prevent diabetes, depending on your genes
A new analysis of a major clinical trial found that vitamin D supplementation reduced diabetes risk in prediabetic adults with certain variations in the vitamin D receptor gene. The study suggests personalized medical care could delay or prevent diabetes onset for millions of Americans living with prediabetes.
Professor Roland Chapurlat receives IOF Olof Johnell Science Award
The International Osteoporosis Foundation has awarded Professor Roland Chapurlat the prestigious IOF Olof Johnell Science Award for his seminal contributions to understanding and managing osteoporosis, osteoarthritis, and skeletal rare bone diseases. He is recognized as one of the leading clinical academics in the field worldwide.
International Osteoporosis Foundation CNS Medal awarded to Professor Radmila Matijevic
Professor Radmila Matijevic received the IOF CNS Medal for her outstanding work in advancing bone health awareness, diagnosis, and management. Her contributions to osteoporosis research and clinical practice have improved patient care in Serbia and the wider Balkan region.
ESCEO-IOF Young Investigator Awards presented to researchers from 16 countries
Twenty-three young investigators from 16 countries received the ESCEO-IOF Young Investigator Awards for their outstanding abstracts submitted to the WCO-IOF-ESCEO 2026 Congress. The awards aim to support and attract young researchers to the field of musculoskeletal research.
Keto diet may improve beta cell function in people with type 2 diabetes
A ketogenic diet has been shown to improve beta-cell function in patients with type 2 diabetes by decreasing proinsulin secretion and reducing pancreas stress. This improvement is associated with changes in the proinsulin-C-peptide ratio, a biomarker of pancreas stress.
IOF honors Professor Thierry Chevalley with President’s Award
Professor Thierry Chevalley has received the prestigious IOF President's Award for his significant contributions to advancing bone health and osteoporosis prevention. With extensive research expertise in geriatrics and bone health, he serves on various scientific committees and leads efforts to develop fracture liaison services.
IOF CSA Medal of Achievement awarded to Professor Noriko Yoshimura
Professor Noriko Yoshimura has received the IOF CSA Medal of Achievement for her pioneering work on epidemiology and prevention of locomotive organ disorders and osteoporosis. Her research, including the ROAD Study, has significantly advanced understanding of musculoskeletal health.
Clinical guidelines on physical activity and exercise therapy for Chinese adults with type 2 diabetes: A clinical practice guideline from the Chinese Society of Endocrinology
The clinical guideline emphasizes personalized care, recommending pre-exercise cardiovascular risk assessment and individualized exercise prescriptions. Adults with T2D are advised to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, or a combination of aerobic and resistance training.
Moving obesity diagnosis beyond BMI may delay treatment
The Endocrine Society suggests that redefining obesity beyond BMI could complicate diagnosis and delay treatment. The proposed framework requires clinicians to prove organ dysfunction is caused by body fat for a clinical obesity diagnosis. This approach may hinder access to effective obesity treatment.
New insights into rare pancreatic tumors that cause low blood sugar
A study by researchers at Institute of Science Tokyo has identified a key gene, DOCK10, involved in abnormal insulin secretion in insulinomas. The findings pave the way for novel diagnostic biomarkers and treatment options.
Two UT MD Anderson researchers elected AAAS Fellows
UT MD Anderson faculty members Theresa Guise and Stephanie Watowich have been elected as AAAS Fellows, honored for their outstanding contributions to science and society. Their research focuses on endocrinology and immunology, with breakthroughs in cancer treatment and patient care.
Data-driven subgroups for 3-year risk stratification of incident diabetes and complications in diabetes-free Chinese adults
A study identified metabolic subgroups in diabetes-free Chinese adults to predict 3-year risk of developing diabetes and related complications. The low-risk subgroup had favorable metabolic profiles, while the high-risk subgroup showed poor glycemic control and increased risks of fatty liver disease and cardiovascular events.
PFAS exposure may weaken teens’ bones
Early-life exposure to PFAS may influence how teens' bones develop during adolescence, leading to lower bone density. The study found that teens with higher PFAS levels had lower forearm bone density, with stronger associations among females.
Development of build better bones: A global resource for osteoporosis self management
A new platform, Build Better Bones, offers evidence-based guidance and practical resources for osteoporosis management. The platform, developed by the International Osteoporosis Foundation, provides a trusted place for people with osteoporosis to start their journey, with a focus on exercise, nutrition, and home safety.
Father’s tobacco use may raise children’s diabetes risk
A mouse study found that a father's nicotine exposure can affect his offspring's ability to process sugar, potentially contributing to diabetes risk. The study's findings suggest that tobacco use in men may be linked to an increased risk of their descendants developing diabetes.
Low testosterone, high fructose: A recipe for liver disaster
A study published in American Journal of Physiology-Endocrinology and Metabolism found that low testosterone and high fructose intake synergistically contribute to liver damage in mice. The researchers discovered that changes in gut microbiota led to increased levels of pyruvate, which promotes fat accumulation in the liver.
Chinese Neurosurgical Journal highlights gut–brain axis in pituitary tumor–related cognitive decline
Pituitary neuroendocrine tumors (PitNETs) are associated with cognitive decline, which may be linked to hormonal dysregulation and gut microbiota alterations. Surgical intervention improves cognitive function, suggesting a potential endocrine mechanism underlying cognitive dysfunction and recovery.
Endocrine Society elects Wu as 2027-2028 President
The Endocrine Society has elected Joy Wu as its 2027-2028 President, a board-certified endocrinologist with a focus on osteoporosis and bone health. Wu is also a leading researcher in stem cell therapies for bone formation and prevention of cancer metastases to bone.
Antifibrotic drug shows promise for premature ovarian insufficiency
Researchers found that an approved antifibrotic drug, finerenone, can reduce ovarian fibrosis and promote follicle growth in women with premature ovarian insufficiency. Clinical trials showed that finerenone improved follicle development and mature oocyte quality in women with POI.
UCF researcher developing new therapy to treat diabetic neuropathy
A UCF researcher is pursuing innovative approaches to treat diabetic neuropathy without relying on pain pills and anti-depressants. Dr. Jim Nichols is investigating overlooked mechanisms in the body that may show how insulin deficiency affects sensation in limbs.
ENDO 2026 opens media registration
The Endocrine Society's annual meeting ENDO 2026 offers journalists the opportunity to discuss groundbreaking research on various hormone-related topics with world-renowned experts. Over 7,200 attendees, 100 exhibitors, and nearly 2,500 abstracts are expected.
ESE and ESPE launch joint transition of care guidance to improve outcomes for young people moving from child to adult endocrine care
The ESE and ESPE have launched a landmark Joint Clinical Practice Guidance to support structured and effective transition of young people with endocrine conditions. The Guidance provides practical, evidence-based recommendations to ensure continuity, safety and quality of care during this critical phase in a patient's life.
Sleep‑aligned fasting improves key heart and blood‑sugar markers
A new study found that aligning overnight fasting with the body's natural sleep-wake rhythm improved cardiovascular and metabolic health. Participants who extended their fast by two hours and dimmed lights three hours before bedtime showed significant improvements in blood pressure, heart rate, and blood-sugar control.
Treatment strategies after denosumab discontinuation in non-metastatic breast cancer treated with AI
A new review highlights the need for planned sequential bone therapy to reduce the risk of spontaneous vertebral fractures after denosumab therapy. Denosumab discontinuation can trigger a 'rebound phenomenon' marked by rapid bone turnover, bone loss, and potentially multiple vertebral fractures.
Endocrine Society announces inaugural Rare Endocrine Disease Fellows Program
The Endocrine Society has announced its inaugural Rare Endocrine Disease (RED) Fellows Program, designed to improve outcomes for people living with rare endocrine diseases. The program addresses critical gaps in awareness, diagnosis, and care through a partnership with the National Organization for Rare Disorders.
Could a living implant end daily insulin injections?
A self-regulating, implantable living technology has been developed to offer hope for millions with diabetes. The implant continuously senses blood-glucose levels, produces insulin within itself, and releases the exact amount needed, eliminating the need for daily injections.
First global consensus on managing vertebral fractures in advanced chronic kidney disease
Vertebral fractures are a devastating complication of advanced kidney disease, associated with increased risk of further fractures and cardiovascular events. The first global consensus statement offers practical recommendations for clinicians to identify and manage vertebral fractures in patients with chronic kidney disease stages G4–G5D.
People with obesity may have a higher risk of dementia
A new study published in The Journal of Clinical Endocrinology & Metabolism found a causal link between high body mass index (BMI) and dementia. High blood pressure was identified as a driving factor behind the increased risk. Researchers suggest that preventing or treating obesity and high blood pressure could help reduce dementia risk.
New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause
A new study published in The Lancet Obstetrics, Gynaecology, & Women's Health found that postmenopausal women receiving hormone therapy lost 35% more weight while taking tirzepatide, a GLP-1-based obesity medication. This research could help develop personalized strategies for managing cardiometabolic risk in postmenopausal women.
Study finds more than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss
A new study found that more than one-in-four adults worldwide may be eligible for GLP-1 use, with women and older individuals among the most eligible. The research emphasizes the need to prioritize global access to these medications, particularly in low- and middle-income countries where obesity rates are highest.
Neural progesterone receptors link ovulation and sexual receptivity in medaka
Researchers found a neuroendocrine mechanism linking ovarian status to brain signals controlling sexual receptivity in female teleosts. Progesterone analogs restored sexual behavior but not ovulation, suggesting a direct neural pathway for hormone reception.
The way our cells respond to oestrogen, the main female sex hormone, depends on how DNA is ‘supercoiled’
New research reveals that DNA's physical property of supercoiling is crucial for cells to respond to oestrogens. The study found that enzymes called topoisomerases regulate DNA coiling and activate target genes.
Tackling the burden of osteoporosis and fragility fractures: The APCO-IOF Asia Pacific Regional Audit
The Asia Pacific Regional Audit highlights key trends, gaps, and opportunities in 22 countries and regions. The audit reveals a steep rise in fracture rates due to poor bone health and an ageing population, with China, Malaysia, and Australia experiencing significant increases.
NEJM Group launches NEJM Clinician
NEJM Clinician curates highly relevant clinical insights from over 150 peer-reviewed journals to give physicians clear guidance without the noise. The weekly publication delivers summaries and commentary in a concise, 30-minute read, helping healthcare providers stay informed and confident in their decisions.
PFAS exposure and endocrine disruption among women
Exposure to single and mixtures of perfluoroalkyl substances (PFAS) was associated with higher odds of endocrine disruption (ED) among women. Certain PFAS compounds, particularly n-PFOS, were found to disrupt endocrine function and harm health.
Global initiative for glycolipid metabolic health
A global initiative has been launched to tackle glycolipid metabolic disorders, which are prevalent and linked to various chronic diseases. The initiative aims to improve public health education and develop an integrated screening-diagnosis-treatment-management system to prevent disease progression.
Anna Gloyn wins 2026 Transatlantic Alliance Award in Endocrinology
Dr. Anna Gloyn has been awarded the fifth Transatlantic Alliance Award for her pioneering research on genetic mechanisms of diabetes and precision medicine. Her collaborative work with colleagues across Europe and the United States has significantly advanced our understanding of the genetic basis of diabetes.
Hormone-disrupting chemicals from plastics shown to promote a chronic inflammatory skin condition
A Johns Hopkins Medicine study found hormone-disrupting chemicals shed by plastics are present in the skin of people with hidradenitis suppurativa, potentially worsening symptoms. The researchers believe reducing exposure could ease HS symptom severity and provide a new avenue of relief.
9th IOF Asia-Pacific Bone Health Conference set to open in Tokyo
The 9th IOF Asia-Pacific Bone Health Conference will bring together healthcare professionals, researchers, and policymakers to exchange knowledge and shape the future of bone health across the region. The conference will feature keynote lectures, sponsored sessions, and a launch of the IOF Asia-Pacific Regional Audit 2025.
Thyroid dysfunction during pregnancy may increase autism risk in children
A new study found that maternal thyroid hormones are crucial for fetal neurodevelopment, and gestational thyroid imbalance increases the risk of autism spectrum disorder. Women with persistent thyroid dysfunction across pregnancy were at a higher risk of having children with autism.
European Society of Endocrinology leads global call to raise awareness of hormone health on World Hormone Day 2026
The European Society of Endocrinology is launching a new campaign to raise awareness about the importance of hormone health. The #BecauseHormonesMatter initiative aims to improve public understanding of hormones and promote practical steps for better hormone health, following the success of last year's campaign.
Root canal treatment reduces heart disease and diabetes risk
A study published in Journal of Translational Medicine found that successful root canal treatment can reduce inflammation linked to heart disease and improve levels of blood sugar and cholesterol. The researchers discovered a link between monitoring blood metabolic markers after dental treatment, which could help assess recovery and risk.
ESE publishes Revised Clinical Practice Guideline for Treatment of Chronic Hypoparathyroidism in Adults
The European Society of Endocrinology has published a revised clinical practice guideline for the treatment of chronic hypoparathyroidism in adults, featuring a new definition and treatment algorithm. The guidelines aim to provide practical guidance for healthcare providers involved in diagnosing and managing the condition.
Why your daily walk might not work as well if you’re on metformin
Researchers from Rutgers University found that metformin blunts improvements in blood vessel function, fitness, and blood sugar control after exercise. This means that people taking metformin may not get the protection they expect to help lower disease risk. The study's lead author, Steven Malin, hopes future research will uncover stra...
CRISPR screen identifies new regulator of androgen receptor in prostate cancer
Researchers from Arc Institute, UCSF, and Fred Hutchinson Cancer Center identified PTGES3 as a key regulator of the androgen receptor in prostate cancer. The study found that PTGES3 contributes to tumor growth and suggests it could be a promising new target for treating aggressive prostate cancers.
Recognising excellence in endocrinology, ESE announces the deserving winners of the 2026 Awards
The European Society of Endocrinology (ESE) has announced the winners of the 2026 ESE Awards, which recognize outstanding contributions to improving knowledge and expertise in endocrinology. This year's winners include Martin Reincke for his work on neuroendocrinology and Maria-Christina Zennaro for her research on hypertension.
From lab to land: How hands-on computer science is building the future
A team of researchers led by Stephen McCormick has uncovered how fish know when to migrate, revealing that their pituitary gland is studded with photoreceptors that can perceive daylight changes. This discovery sheds light on the enduring migration mystery and will help in planning for climate change's impact on migrating fish populati...